The activation of the NF-κB signalling pathway induces upregulations of proinflammatory cytokines including TNFα, IL-6, and IL-1β and oxidative stress, and pharmacological approaches are being developed to block this transcription factor to prevent inflammation and oxidative stress-associated pulmonary diseases [34]. Here, NFKB1 is linked to lung disorder.